Q32 Bio Inc (QTTB) recent activity suggests a positive outlook with the last week’s performance of 51.60%

Shaun Noe

On Friday, Q32 Bio Inc (NASDAQ: QTTB) was -8.29% drop from the session before settling in for the closing price of $3.62. A 52-week range for QTTB has been $1.35 – $28.06.

Annual sales at Healthcare sector company grew by 31.75% over the past five years. When this article was written, the company’s average yearly earnings per share was at 58.13%. With a float of $4.55 million, this company’s outstanding shares have now reached $12.30 million.

Q32 Bio Inc (QTTB) Insider and Institutional Ownership

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Q32 Bio Inc stocks. The insider ownership of Q32 Bio Inc is 62.99%, while institutional ownership is 10.86%. The most recent insider transaction that took place on Dec 02 ’25, was worth 77,871. In this transaction CEO of this company sold 22,506 shares at a rate of $3.46, taking the stock ownership to the 99,000 shares. Before that another transaction happened on Dec 02 ’25, when Company’s CFO and President sold 9,072 for $3.46, making the entire transaction worth $31,395. This insider now owns 39,938 shares in total.

Q32 Bio Inc (QTTB) Latest Financial update

Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -1.16 earnings per share (EPS) during the time that was better than consensus figure (set at -1.53) by 0.37.

According to the Wall Street analysts, stocks earnings will be around 58.13% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 9.95% during the next five years compared to 31.75% growth over the previous five years of trading.

Q32 Bio Inc (NASDAQ: QTTB) Trading Performance Indicators

You can see what Q32 Bio Inc (QTTB) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.57.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.45, a number that is poised to hit -0.97 in the next quarter and is forecasted to reach -2.60 in one year’s time.

Technical Analysis of Q32 Bio Inc (QTTB)

Q32 Bio Inc (NASDAQ: QTTB) saw its 5-day average volume 35.63 million, a positive change from its year-to-date volume of 1.27 million. As of the previous 9 days, the stock’s Stochastic %D was 35.29%.

During the past 100 days, Q32 Bio Inc’s (QTTB) raw stochastic average was set at 36.48%, which indicates a significant increase from 31.69% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.47 in the past 14 days, which was higher than the 0.26 volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $2.67, while its 200-day Moving Average is $2.07. Nevertheless, the first resistance level for the watch stands at $3.58 in the near term. At $3.85, the stock is likely to face the second major resistance level. The third major resistance level sits at $4.03. If the price goes on to break the first support level at $3.13, it is likely to go to the next support level at $2.95. The third support level lies at $2.68 if the price breaches the second support level.

Q32 Bio Inc (NASDAQ: QTTB) Key Stats

There are 12,304K outstanding shares of the company, which has a market capitalization of 40.85 million. As of now, sales total 0 K while income totals -47,730 K. Its latest quarter income was 0 K while its last quarter net income were -7,390 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.